Patient Preference Study
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-12-19
- Last Posted Date
- 2014-07-11
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 129
- Registration Number
- NCT00576342
Acute Comfort and Blur of Systane and Optive
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-12-06
- Last Posted Date
- 2012-02-02
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 40
- Registration Number
- NCT00568386
Safety and Efficacy of Vitreous Delineating Agent During Vitrectomy
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-09-20
- Last Posted Date
- 2012-04-05
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 60
- Registration Number
- NCT00532415
A Single Dose Comfort Comparison of Travatan Z in One Eye Versus Xalatan in the Opposite Eye in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension
- First Posted Date
- 2007-09-11
- Last Posted Date
- 2012-05-18
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 54
- Registration Number
- NCT00527592
IOP Lowering Efficacy of Travoprost/Brinzolamide Fixed Combination Ophthalmic Suspension in Patients With Open-Angle Glaucoma or Ocular Hypertension
Phase 2
Completed
- Conditions
- First Posted Date
- 2007-09-11
- Last Posted Date
- 2012-04-16
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 136
- Registration Number
- NCT00527501
- Locations
- 🇺🇸
Artesia, Artesia, California, United States
Success of Transitioning Uncontrolled Glaucoma Patients From Prior Mono or Adjunctive Therapy to DuoTrav
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-08-23
- Last Posted Date
- 2016-11-18
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 522
- Registration Number
- NCT00519753
- Locations
- 🇩🇪
Mainz, Mainz, Germany
Adherence Assessment With Travalert Dosing Aid
- First Posted Date
- 2007-07-30
- Last Posted Date
- 2012-07-12
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 102
- Registration Number
- NCT00508469
- Locations
- 🇪🇸
Zaragoza, Zaragoza, Spain
A Clinical Study of Tobradex AF
Phase 3
Completed
- Conditions
- First Posted Date
- 2007-05-14
- Last Posted Date
- 2008-07-29
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 900
- Registration Number
- NCT00473070
- Locations
- 🇺🇸
Pittsburgh, Pittsburgh, Pennsylvania, United States
Phase II Study of AL-2178 (FID 109980) in the Treatment of Dry Eye
Phase 3
Completed
- Conditions
- First Posted Date
- 2007-05-09
- Last Posted Date
- 2012-06-05
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 750
- Registration Number
- NCT00471419
- Locations
- 🇺🇸
Cleveland, Cleveland, Ohio, United States
Study of Travatan and Cosopt in Primary Open-Angle Glaucoma or Ocular Hypertension
Phase 4
Terminated
- Conditions
- Interventions
- First Posted Date
- 2007-05-09
- Last Posted Date
- 2012-04-11
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 46
- Registration Number
- NCT00471068
- Locations
- 🇵🇹
Coimbra, Coimbra, Portugal
© Copyright 2024. All Rights Reserved by MedPath